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GEN SHIMIZU,  MD,* YUZO HIROTA,  MD, KE ISHIRO KAWAMURA,  MD 
Osaka, Japan 
Objectives. Our aim was to determine whether there is a final 
transition from left ventricular hypertrophy to congestive heart 
failure in the late stage of essential hypertension. 
Background. A theoretic model using the concept of systolic 
transmural nonuniform wall thickening was applied to develop a 
concentric two-shell geometry allowing evaluation of the mechan- 
ics of circumferential midwall fibers. 
Methods. We evaluated pressure-volume data from 46 normal 
control subjects (control group) and 70 patients with hyperten- 
sion: 33 without hypertrophy (hypertension only group), 14 with 
hypertrophy (hypertrophy group) and 23 with heart failure in 
addition to hypertrophy (heart failure group). 
Results. End-diastolic volume index was higher in the heart 
failure group than in the control group (p < 0.01). Although left 
ventricular wall thickness and mass index were increased in both 
the hypertrophy and the heart failure group, concentricity indexes 
as assessed by ratios of left ventricular wall thickness to dimen- 
sion and mass index to end-diastolic volume index were maximal 
in the former. Although endocardial and standard midwall frac- 
tional shortening did not differ among the control, hypertension 
only and heart failure groups, that of the modified midwall by 
concentric two-shell geometry was decreased in the hypertrophy 
and the heart failure groups (p < 0.05). The Hotelling T 2 test and 
Mahalanobis distance clearly discriminated the latter two groups 
with end-systolic stress and modified midwall fractional shorten- 
ing relation. 
Conclusions. A fitting segmented regression model predicted a 
progression to hypertrophy and identified a transition from 
hypertrophy to heart failure by a combination of modified midwall 
fractional shortening and concentricity indexes. 
(J Am CoU Cardiol 1995;25:888-94) 
A final outcome of untreated essential hypertension is conges- 
tive heart failure, as reported by the Framingham studies (1,2). 
Although this course of events has been widely accepted, we 
have not precisely understood the exact pathophysiologic 
mechanism by which compensated left ventricular hypertrophy 
is followed by congestive heart failure. Because heart failure is 
due to inability of the pump function to provide adequate 
cardiac output, the occurrence of the failure state can be due 
to abnormalities in the determinants of cardiac function, that 
is, contractility, preload or afterload (3). Thus, various aspects 
of ventricular function have been evaluated to understand the 
development of congestive heart failure. Currently, it appears 
that either systolic function or diastolic properties contribute 
to congestive heart failure in concentric hypertrophy due to 
pressure overload caused by essential hypertension (4-6). 
Recently, we (7) found normal chamber and depressed 
myocardial systolic function in patients with essential hyper- 
tension who had concentric hypertrophy without heart failure. 
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Accordingly, reduced systolic function might be expected to 
provoke a failure state in the late stage of hypertension i
patients who are not receiving appropriate medication. In this 
study, we evaluated the contractile state in patients with 
hypertrophy and failure due to essential hypertension by a 
precise assessment ofventricular function. Our objectives were 
to identify the initial adaptation and to predict he sequence of 
decompensation from concentric hypertrophy to congestive 
heart failure associated with essential hypertension. 
Methods  
Study group. Left ventricular cineangiograms from 116 
patients who underwent diagnostic ardiac atheterization for 
evaluation of chest pain, a heart murmur or clinical evidence of 
congestive heart failure (New York Heart Association func- 
tional class II to IV) were selected for this study. All patients 
had given informed written consent. Forty-six subjects (33 
men, 13 women) without evidence of heart disease served as a 
control group. Forty-seven patients without congestive heart 
failure and 23 with congestive heart failure had a history of 
essential hypertension (blood pressure >160/90 mm Hg). No 
patient had cineangiographic evidence of coronary artery 
disease. The patients with hypertension and no congestive 
heart failure were classified into two groups on the basis of left 
ventricular mass index (Table 1). Thirty-three (hypertension 
only group) (18 men, 15 women) had a normal mass index 
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Table 1. Basic Hemodynamic  Variables 
HR 
Age (beats/ LVSP LVEDP LVESP EDVI ESVI EF h LVMI cr ed a es 
(yr) min) (ram Hg) (mm Hg) (ram Hg) (ml/m 2) (ml/m 2) (%) (cm) (g/m 2) (g/cm ~) (g/cm 2) 
NC 44 ± 13 70 + 13 123 _+ 12 9 ± 3 101 ± 14 78 + t6 26 _+ 7 66 ± 6 0.8 _~ 0.1 82 ± 18 30 _+ 12 150 _+ 42 
HN 53 + 8 70 ± 11 149 - 22 10 + 3 120 ± 20 72 _+ 15 22 ± 8 69 -+ 10 0.9 + 0.2 88 _+ 17 29 -+ 12 152 ± 53 
HH 54 _+ 7 69 _'_ 11 148 _+ 17 10 ± 3 125 ± 13 82 ± 24 24 _+ 8 70 -+ 6 1.3 ± 0.2 155 _+ 18 20 _+ 7 112 _+ 27 
HF 50 ± 12 79 _+ 22 156 ± 24 12 + 8 128 ± 24 133 ± 47 88 _+ 44 38 = 13 1.2 _+ 0.2 186 _+ 52 3l ± 19 231 _+ 80 
p Values 
NC vs. HN < 0.01 NS < 0.01 NS < 0.01 NS NS NS NS NS NS NS 
NC vs. HH < 0.0l NS < 0.01 NS < 0.0I NS NS NS < 0.01 < 0.01 NS < 0.01 
NC vs. HF < 0.05 NS < 0.01 < 0.05 < 0.01 < 0.01 < 0.01 < 0.01 < 0.01 < 0.01 NS < 0.01 
HN vs. HH NS NS NS NS NS NS NS NS < 0.01 < 0.01 NS < 0.01 
HN vs. NF NS NS NS < 0.05 NS < 0.0l < 0.01 < 0.01 < 0.01 < 0.01 NS < 0.01 
HH vs. HF NS NS NS < 0.05 NS < 0.01 < 0.01 < 0.01 NS < 0.01 NS < 0.01 
Data presented are mean value _~ SD or p value. EDVI - end-diastolic volume index; EF - ejection fraction: ESVI - end-systolic volume index; h = end-diastolic 
wall thickness; HF = hypertension with left ventricular hypertrophy and congestive heart failure; HH - hypertension with left ventricular hypertrophy; HN = 
hypertension without left ventricular hypertrophy; HR - heart rate; LVEDP - left ventricular end-diastolic pressure; LVESP = left ventricular end-systolic pressure; 
LVMI - left ventricular mass index; LVSP left ventricular systolic pressure: NC normal control subjects; o- ed - end-diastolic circumferential midwall stress; o- 
es = end-systolic circumferential midwall stress. 
(within the mean + 2 SD of the control group value). Fourteen 
patients (hypertrophy group) (11 men, 3 women) had an 
increased left ventricular mass index (greater than the mean + 
2 SD of the control group value). The other 23 patients (heart 
failure group) (19 men, 4 women) had both congestive heart 
failure and an increased left ventricular mass index. 
Cardiac catheterization. The catheterization procedure 
has been reported elsewhere (8). Left ventricular cineangio- 
grams were obtained in the right anterior oblique projection. 
Simultaneous recordings of the electrocardiogram (ECG), left 
ventricular pressure, intracardiac phonocardiogram and cine 
pulse were also obtained. Left ventricular geometry was mea- 
sured at end-diastole and end-systole, which were defined as 
the frames obtained at the initiation of the QRS complex and 
of the second heart sound, respectively. We measured the area 
(A) and long radius (L) of these frames, where L is one-half 
the long axis of the ventricular silhouette. The minor radius 
(D), where D is one-half the minor diameter, and left ventric- 
ular volume were calculated with the formulas of the area- 
length method: D = A/0rL), and Left ventricular volume = 
47rD2L/3. 
Ejection fraction was calculated as (End-diastolic volume -
End-systolic volume)fEnd-diastolic volume. End-diastolic wall 
thickness (h) was measured at the midanterior position on the 
left ventricular cineangiogram. Left ventricular mass was cal- 
culated by using the formula (9): Left ventricular mass - 
4~(D + h)Z(L + h) - D2L]/3. Left ventricular mass was divided 
by body surface area to obtain left ventricular mass index. 
Model and calculations. The left ventricular model was 
reported in our previous tudy (7). Briefly, the left ventricle 
was represented by an ellipsoid model with uniform wall 
thickness. The left ventricular wall was divided into inner and 
outer shells, thus defining a concentric two-shell geometry. The 
volume of each shell was assumed to be constant throughout 
the cardiac ycle. Accordingly, an instantaneous wall thickness 
and midwall fiber position could be calculated by a concentric 
two-shell geometry that presented a model of systolic transmu- 
ral nonuniform wall thickening. 
The degree of concentric hypertrophy was assessed by the 
ratios of left ventricular end-diastolic wall thickness to minor 
diameter and of left ventricular mass index to end-diastolic 
volume index (g/ml) as concentricity indexes (10,5). Three 
methods were used to calculate circumferential fractional 
shortening (%) at the equator of the ellipsoid: endocardial 
fractional shortening, standard midwall fractional shortening 
using the conventional ssumption of systolic transmural uni- 
form wall thickening, and modified midwall fractional short- 
ening using concentric two-shell geometry and the systolic 
transmural nonuniform wall thickening model. Left ventricular 
end-diastolic and end-systolic midwall circumferential stresses 
(g/cm 2) were calculated by the following formula: 
= p (B/h) (1 - h/2B - B2/2A2), 
where p is left ventricular pressure, h is wall thickness and A 
and B are long and short radii to the midwall fiber position, 
respectively (A = L + h i and B = D + hi, where h i = thickness 
from endocardium to the midwall circumferential fiber posi- 
tion). These stress calculations incorporate the systolic trans- 
mural nonuniform wall thickening concept (11,12). 
Statistics. Data are presented as mean value + SD. One- 
way analysis of variance and Duncan multiple comparisons 
were used; differences were considered significant if the p 
value was < 0.05. The stress-shortening relation was assessed 
by a two-dimensional framework of end-systolic stress and 
fractional shortening and the application of the Hotelling T 2 
test and Mahalanobis distance with 95% confidence ellipsoids 
(13,14). 
A relation between the degree of concentric hypertrophy 
and fractional shortening was evaluated by a fitting segmented 
regression model to detect he end of compensatory h pertro- 
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Figure 1. Concentricity indexes. The degree of con- 
centric hypertrophy is shown by the ratio of end- 
diastolic wall thickness (h) to minor diameter (R) (left 
panel) and the ratio of left ventricular mass index 
(LVMI) to end-diastolic volume index (EDVI) (right 
panel). Data are mean value _+ SD and compared by 
one-way analysis of variance and Duncan multiple 
comparisons. HF = hypertension with left ventricular 
hypertrophy and congestive heart failure; HH = hy- 
pertension with left ventricular hypertrophy; HN = 
hypertension without left ventricular hypertrophy; 
NC = normal control subjects. 
phy and the change to congestive heart failure. The model is a 
further application of linear regression to determine a transi- 
tional coordinate as a flexion point on regression lines of 
two-dimensional data with concentricity index and fractional 
shortening (15). Thus, the fitting segmented regression model 
provides two linear regression lines from pairs of data. We 
applied the bootstrap method to approve a propriety of the 
transitional coordinates. This analysis involves repeated calcu- 
lations for the fitting segmented regression model with ran- 
domized coordinates allowing duplication of data to make the 
same number of whole coordinates; therefore, each calculation 
may discard some of the coordinates in a random fashion. The 
range of transitional coordinates on modified midwall frac- 
tional shortening was obtained as mean value _+ SD from 100 
pairs of data in this study (16). 
Resu l ts  
The hemodynamic characteristics of the four study groups 
are summarized in Table 1. Although left ventricular systolic 
pressure was elevated in all three hypertensive groups, end- 
diastolic pressure was increased only in the hypertensive 
patients with heart failure. End-diastolic volume index was also 
markedly higher in the heart failure group than in the normal 
group. Left ventricular end-diastolic wall thickness and mass 
index were greater in the hypertrophy group and the heart 
failure group by study design. Figure 1 shows concentricity 
indexes of left ventricular dimension and mass to volume. 
These indexes--that of dimension (normal 0.16 + 0.03; hyper- 
tension only 0.18 4- 0.04; hypertrophy 0.25 _+ 0.06; heart failure 
0.20 ± 0.05) and that of mass/volume ratio (normal 1.1 + 0.2; 
hypertension only 1.3 ± 0.4; hypertrophy 2.0 ~ 0.6; heart 
failure 1.5 _+ 0.4 g/ml)--were larger in the hypertrophy group 
and the heart failure group even though the left ventricular 
cavity was dilated only in the heart failure group. Endocardial, 
standard and modified midwall fractional shortening are com- 
pared among all groups in Figure 2. All three types of 
fractional shortening were significantly less in the heart failure 
group. Although endocardial fractional shortening (normal 
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Figure 2. Comparisons offractional shortening in
the four patient groups. Fractional shortening, de- 
fined as endoeardial fractional shortening (eFS) 
(left panel), standard midwaU fractional shortening 
(sFS) (middle panel) and modified midwall frac- 
tional shortening (mFS) (fight panel), was assessed 
by one-way analysis of variance and Duncan multi- 
ple comparisons among individual groups. Data are 
mean value _+ SD. Abbreviations a in Figure 1. 
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Table 2. Mahalanobis Distances and p Values by Hotelling T 2 Test 
in End-Systolic Stress and Fractional Shortening Relations 
NC-HN NC-HH NC-HF HN-HH HN-HF HH-HF 
eFS 7.23 31.54 272.22 20.63 181.43 166.51 
p value 0.42 0.07 0.00 0.12 0.00 0.00 
sFS 0.47 35.44 335.67 24.05 178.48 142.74 
p value 0.94 0.05 0.00 (/.08 0.00 0.00 
mFS 0.12 43.57 340.45 24.95 164.21 120.52 
p value 0.99 0.02 0.00 0.08 0.00 0.00 
p values calculated by Hotelling T2 test. eFS - Mahalanobis distance by 
endocardial fractional shortening; mFS Mahalanobis di tance by modified 
midwall fractional shortening; sFS - Mahalanobis distance by standard midwall 
fractional shortening; other abbreviations as in Table l. 
36 + 5%; hypertension only 38 _+ 9%; hypertrophy 40 _+ 6%; 
heart failure 17 _+ 8%) and standard midwall fractional 
shortening (normal 24 _+ 4%; hypertension only 24 +_ 6%; 
hypertrophy 22 + 4%; heart failure 10 + 5%) did not differ 
statistically among the normal, hypertension only and hyper- 
trophy groups, the significantly smaller value of modified 
midwall fractional shortening obtained in the hypertrophy 
group suggested ecreased systolic function in this group 
(normal 21 _+ 4%; hypertension only 21 _+ 5%; hypertrophy 
19 -- 4%; heart failure 9 _+ 4%). 
The Hotelling T 2 test was applied to discriminate individual 
groups for the assessment of stress-shortening relation (Table 
2). Mahalanobis distances with 95% confidence llipsoids were 
obtained to confirm the results of the Hotelling T 2 test. The 
heart failure group was easily separated on the basis of 
end-systolic stress and each type of fractional shortening (Fig. 
3). The hypertrophy group was most clearly discriminated from 
the other groups by both axes on the framework of end-systolic 
stress and modified midwall fractional shortening relation 
rather than those of endocardial and standard midwall frac- 
tional shortening relations (Fig. 3, Table 2). 
A fitting segmented regression model did not show a 
significant correlation between the concentricity index (left 
ventricular end-diastolic wall thickness/minor diameter atio) 
and endocardial fractional shortening in the upper panel of 
Figure 4. There was no significant relation between the con- 
centricity index of mass/volume ratio and endocardial frac- 
tional shortening. Standard midwall fractional shortening did 
not reveal any relation to either concentricity index. The same 
procedure was applied to correlate the concentricity index of 
dimension and modified midwall fractional shortening in the 
lower panel of Figure 4. In addition to significant bidirectional 
regression lines (the contribution rate was either 31.6% be- 
tween modified midwall fractional shortening and the concen- 
tricity index of dimension in Figure 4 or 29.6% between 
modified midwall fractional shortening and the concentricity 
index of mass/volume ratio), the analyses also identified a 
flexion point between the regression lines. The coordinates 
indicated pairs of modified midwall fractional shortening 
(mFS) = 11.40% and the concentricity index of dimension 
(h/R) = 0.25 in Figure 4 and modified midwall fractional 
shortening (mFS) = 11.33% and the concentricity index of 
mass/volume ratio (LVMI/EDVI) = 1.90 g/ml. The propriety 
Figure 3. Stress-shortening relations by multiple comparisons. Stress- 
shortening relation was evaluated by Hotelling T ~ test and Mahalano- 
bis distances with 95% confidence ellipsoids using the two-dimensional 
framework. End-systolic stress (aes) is on the abscissa, and fractional 
shortening (FS) is on the ordinate. Endocardial fractional shortening 
(eFS) is shown in the left panel; modified midwall fractional shortening 
(mFS) (right panel) was found to better discriminate individual 
groups. CHF - congestive heart failure; LVH = left ventricular 
hypertrophy; + = present; - = not present; other abbreviations a in 
Figure 1. 
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Figure 4. Concentricity index and fractional shortening. 
Relation between the concentricity index by the ratio of left 
ventricular end-diastolic wall thickness (h) to minor diam- 
eter (R) on the ordinate and fractional shortening (FS) on 
the abscissa was evaluated by a fitting segmented regres- 
sion model. Although there is no significant relation be- 
tween concentricity ndex and endocardial fractional short- 
ening (eFS) in the upper panel, the analytic model could 
determine a transitional coordinate from compensated to 
decompensated groups between regression lines with an 
application of modified midwall fractional shortening 
(mFS) in the lower panel. Abbreviations a in Figures 1 
and 3. 
of these flexion points of modified midwall fractional shorten- 
ing was approved by the bootstrap method (10.56 _+ 0.88% for 
the concentricity index of dimension or 10.58 _+ 0.82% for the 
concentricity index of mass/volume ratio). 
Discuss ion  
Stages of concentric hypertrophy. The ventricular e- 
sponse to pressure overload includes the development of 
concentric hypertrophy as an initial response to compensate 
left ventricular function against he increased load. Whether or 
not contractility is preserved in concentric hypertrophy, the 
abnormal oading condition leads to decompensation a d 
congestive heart failure. In his review, Meerson (17) described 
three stages of hypertrophy: developing hypertrophy, compen- 
satory hypertrophy and heart failure. Although his classifica- 
tion is not fully accepted, it has been useful in understanding 
the progressive r sponse to pressure overload. 
Recently, Weber and coworkers (18,19) refined this concept 
on the basis of their mechanical, biochemical nd morphologic 
studies. Briefly, the first phase is an evolutionary phase in 
which the structure and function of the myocardium change as 
remodeling occurs in response to an excessive load. A physio- 
logic phase follows, in which the remodeled myocardium is in 
balance and may revert o normal if excessive load is removed. 
In the third, pathologic phase, ventricular pump function is 
obviously abnormal. Although their studies provide clues to 
the recognition of clinical hypertrophy and failure, an exact 
point of transition from the end of compensatory h pertrophy 
to congestive heart failure has not been elucidated. 
Application of concentric two-shell geometry. Although 
several experimental studies (12,20) have utilized our theoretic 
model, clinical applications of modified midwall mechanics 
have totally depended on theoretic onsideration i  echocar- 
diographic (21,22) and angiographic (7) studies. Basically, we 
cannot race a movement of a myocardial fiber within the left 
ventricular wall during a cardiac ycle unless intramyocardial 
markers have been implanted (23). However, ecently reported 
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developments in nuclear magnetic resonance imaging could 
potentially provide a method of detecting myocardial fiber 
movement within the left ventricular wall in the beating human 
heart (24). Although these reports did not focus on the 
mechanics of circumferential midwall fibers, further develop- 
ment of this technique by tissue tagging may be able to clarify 
our concept, permitting clinical application. 
Rationale for using multiple comparisons. Conventional 
assessment of the force-velocity relation, which may indicate 
the status of myocardial contractility, has depended on regres- 
sion analysis. This relation is derived from force-length- 
velocity data obtained from isolated papillary muscles. Many 
investigators have applied this concept in evaluating ventricu- 
lar function with either cineangiographic (25) or echocardio- 
graphic (26) measurements. When evaluating contractile state, 
a linear regression is calculated to assess a relation between 
two independent variables, and confidence limits are obtained 
to compare data with those of other groups. Because this 
analytic method is primarily designed to evaluate a statistical 
relation in a single group, our conventional statistical method 
might not be adequate to compare multiple groups. In this 
study, we compared cardiac contractile states among normal 
control subjects and three groups of hypertensive patients by 
assessing the degree of concentric hypertrophy and the pres- 
ence of congestive heart failure. The rationale for applying the 
Hotelling T ~ test and Mahalanobis confidence llipsoids is that 
their use allowed simultaneous comparison of a pair of vari- 
ables such as end-systolic stress and fractional shortening (27). 
Significance of hypertrophy for congestive heart failure. 
Several studies (28,29) have reported an inverse relation 
between left ventricular hypertrophy and filling index, suggest- 
ing a diastolic participation i  the development of congestive 
heart failure. We (21) have previously demonstrated a similar 
relation between the degree of left ventricular hypertrophy and 
fiber lengthening of the circumferential midwall fibers pre- 
sented by modified midwall mechanics. Accordingly, we have 
suggested a direct correlation between left ventricular hyper- 
trophy and diastolic properties. Janicki and Matsubara (30) 
summarized the significance of collagen remodeling in provok- 
ing diastolic dysfunction in the pressure-overloaded heart. 
Capasso et al. (31) reported ventricular emodeling due to 
regression of hypertrophic cells and replacement fibrosis fol- 
lowed by left ventricular dilation. Weber and Brilla (32) 
suggested that their experimental data indicated that conges- 
tive heart failure developed in response to diastolic failure 
followed by systolic failure. Thus, the degree of concentric 
hypertrophy could be important in evaluating mechanisms for 
the development of congestive heart failure. 
We normalized the degree of concentric hypertrophy as 
concentricity indexes by applying left ventricular end-diastolic 
wall thickness/minor diameter atio and left ventricular mass 
index/end-diastolic volume index ratio. Several patients in the 
heart failure group had severe concentric hypertrophy as 
assessed by left ventricular end-diastolic wall thickness/minor 
diameter atio (>0.27) and left ventricular mass index/end- 
diastolic volume index (>2.2 g/ml) with a small decrement of 
ejection fraction (50% < ejection fraction < 60%), endocar- 
dial fractional shortening (25% < endocardial fractional short- 
ening < 33%) and modified midwall fractional shortening 
(13% < midwall fractional shortening < 19%). In these 
patients, diastolic properties might provide the main contribu- 
tion to the occurrence of congestive heart failure even though 
myocardial systolic function was minimally depressed. Eventu- 
ally, further systolic failure may lead to development of overt 
congestive heart failure. Thus, our clinical observations appear 
to be consistent with the experimental findings of Weber and 
Brilla (32). 
Final transition from hypertrophy to failure. Although we 
estimated the effects of left ventricular hypertrophy on ventric- 
ular function in various aspects, we did not clarify a transition 
process from the compensatory stage to a state of congestive 
heart failure. The fitting segmented regression model could 
only trace that process and identify a flexion point by statisti- 
cally analyzing all the grouped ata (15). Neither endocardial 
nor standard midwall fractional shortening could determine a 
transition point from compensatory h pertrophy to congestive 
heart failure. In contrast, modified midwall fractional shorten- 
ing could predict the progression from hypertension without 
left ventricular hypertrophy to that with hypertrophy and 
identify the transition from compensated hypertrophy to hy- 
pertrophy with congestive heart failure in a two-dimensional 
framework of modified midwall fractional shortening and a 
degree of concentric hypertrophy. 
Limitations of the study. Follow-up of individual patients 
and serial examination of angiographic studies would provide 
important data not provided by our study. Although our study 
did not show a sequential response to pressure overload in 
each patient, naturally occurring variations could reflect an 
individual process from hypertrophy tocongestive heart failure 
(33,34). Thus, the ability of this method to identify the 
transition from compensated to decompensated states in indi- 
vidual patients must await further studies. 
We express great appreciation to Mr. Takao Soda, Shiogi Kaiseki Center, for 
assistance in statistical analyses of the data and graphic presentations. 
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